AptaShape ApS
Private limited companyCVR 44517132Aarhus CActive
AptaShape ApS is a private limited company, based in Aarhus C, active in research and experimental development on natural sciences and engineering, founded in 2023. Net profit rose 1038% from 2024 to 2025, ending at DKK 129k. Equity grew to DKK 240k in 2025. 8 people are registered in the company's management and ownership.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 207% (2024 → 2025), to DKK 351k.
- Net profit rose 1,038% (2024 → 2025), to DKK 129k.
- Equity rose 116% (2024 → 2025), to DKK 240k.
Management and owners, last 24 months
- New owners registered: Jørgen Kjems (09/12/2024).
Registrations, last 24 months
- 03/06/2025: Moved to Universitetsbyen 14, 8000 Aarhus C
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
- 30/12/2024: Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | 115 | 351 | +206.5% |
| Profit before tax | 15 | 165 | +1,038.9% |
| Net profit | 11 | 129 | +1,038% |
| Total assets | 261 | 563 | +115.4% |
| Equity | 111 | 240 | +115.8% |
| Liabilities | 150 | 308 | +105.2% |
| Cash and cash equivalents | 259 | 496 | +91.6% |
| Average number of employees | 4 | 0 | −100% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 29/05/2026 | The company | PDF not statedXBRL |
| 2024 | 21/12/2023 – 31/12/2024 | 16/06/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Position in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 56,872of 69,742 Better than 18% | No. 49,113of 69,964 Better than 30% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 149of 323 Better than 54% | No. 190of 329 Better than 42% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 12,888of 16,614 Better than 22% | No. 7,995of 16,661 Better than 52% |
| All companies of type ApS66,508 companies in the comparison | No. 54,711of 66,379 Better than 18% | No. 45,143of 66,505 Better than 32% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- AptaShape ApSDKK 351k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- AptaShape ApSDKK 129k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- AptaShape ApSDKK 240k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- AptaShape ApS4
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Pme Holding ApS10%
- Gry Louise Husby Larsen5%
- Claus Bus15%
- Asger Givskov Jørgensen15%
- Magnusson Holding ApS15%
- Emvijo Initiative ApS20%
- Jørgen Kjems20%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Nils Erik Magnusson | CEO | 16/04/2024 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Peter Mørch Eriksen | Chair of the board | 16/04/2024 |
| Daniel Miotto Dupont | Board member | 16/04/2024 |
| Claus Bus | Board member | 16/04/2024 |
| Asger Givskov Jørgensen | Board member | 16/04/2024 |
- Founders
- Pme Holding ApS
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Peter Mørch Eriksen | Director | 21/12/2023 | 16/04/2024 |
Signing rule: Selskabet tegnes af en direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse.
Address and production units
1 active production unitsUniversitetsbyen 14
8000 Aarhus C
| Production unit | Address | Employees | P number |
|---|---|---|---|
| AptaShape ApS | Universitetsbyen 14, 8000 Aarhus C | 4 | 1029944128 |
Purpose
Selskabets formål er at drive virksomhed med handel og produktion samt hermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
22 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20253 changesaccounts 1 · address 1 · industry 1
- AccountsAnnual report for 2024 published
- AddressMoved to Universitetsbyen 14, 8000 Aarhus C
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202415 changesindustry 1 · ownership 6 · address 1 · capital 1 · management 6
- IndustryIndustry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
- OwnershipJørgen Kjems registered as owner (20%)
- AddressMoved to Universitetsbyen 52, st. 14, 8000 Aarhus C
- CapitalShare capital changed from 40,000 DKK to 100,000 DKK
- ManagementPeter Mørch Eriksen appointed chair of the board
- ManagementNils Erik Magnusson appointed ceo
- ManagementDaniel Miotto Dupont appointed board member
- ManagementClaus Bus appointed board member
- ManagementAsger Givskov Jørgensen appointed board member
- ManagementPeter Mørch Eriksen stepped down as director
- OwnershipClaus Bus registered as owner (15%)
- OwnershipAsger Givskov Jørgensen registered as owner (15%)
- OwnershipMagnusson Holding ApS registered as owner (15%)
- OwnershipEmvijo Initiative ApS registered as owner (20%)
- OwnershipGry Louise Husby Larsen registered as owner (5%)
20233 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as AptaShape ApS
- ManagementPeter Mørch Eriksen appointed director
- OwnershipPME HOLDING ApS registered as owner (10%)
Related companies
Same industry in Aarhus
- Vestas Wind Systems A/S3,108 employees
- SEGES Innovation P/S520 employees
- Alx A/S109 employees
- NMD Pharma A/S64 employees
- Innovationscenter for Økologisk Landbrug P/S52 employees
- Cercare Medical A/S28 employees
Same people in management
- Hottinger Brüel & Kjær A/Svia Peter Mørch Eriksen
- Vitrolife A/Svia Peter Mørch Eriksen
- Deltek Danmark A/Svia Peter Mørch Eriksen
- Bioporto Diagnostics A/Svia Gry Louise Husby Larsen
- Brüel & Kjær Vibro A/Svia Peter Mørch Eriksen
- Trebo ApSvia Peter Mørch Eriksen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.